146 related articles for article (PubMed ID: 34652370)
21. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
22. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
[TBL] [Abstract][Full Text] [Related]
23. CF versus CRMS: diagnostic challenges in cystic fibrosis.
Temme R; Roggenbuck J; McNamara J
Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
[TBL] [Abstract][Full Text] [Related]
25. [Neonatal screening for cystic fibrosis].
Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
[TBL] [Abstract][Full Text] [Related]
26. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
[TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.
Castellani C; Picci L; Scarpa M; Dechecchi MC; Zanolla L; Assael BM; Zacchello F
Am J Med Genet A; 2005 Jun; 135(2):142-4. PubMed ID: 15832355
[TBL] [Abstract][Full Text] [Related]
28. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis newborn screening: outcome of infants with normal sweat tests.
Edmondson C; Grime C; Prasad A; Cowlard J; Nwokoro CEC; Ruiz G; Wallis C; Balfour-Lynn IM
Arch Dis Child; 2018 Aug; 103(8):753-756. PubMed ID: 29113966
[TBL] [Abstract][Full Text] [Related]
30. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
31. The role of neonatal screening in nutritional evolution in the first 12 months after diagnosis of cystic fibrosis.
Martins JP; Forte GC; Simon MISDS; Epifanio M; Pinto LA; Marostica PJC
Rev Assoc Med Bras (1992); 2018 Nov; 64(11):1032-1037. PubMed ID: 30570057
[TBL] [Abstract][Full Text] [Related]
32. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
[TBL] [Abstract][Full Text] [Related]
33. Neonatal cystic fibrosis screening: Analysis and differences in immunoreactive trypsin levels in newborns with a positive screen.
Arrudi-Moreno M; García-Romero R; Samper-Villagrasa P; Sánchez-Malo MJ; Martin-de-Vicente C
An Pediatr (Engl Ed); 2021 Jul; 95(1):11-17. PubMed ID: 34140271
[TBL] [Abstract][Full Text] [Related]
34. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
[TBL] [Abstract][Full Text] [Related]
35. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland.
Barben J; Gallati S; Fingerhut R; Schoeni MH; Baumgartner MR; Torresani T;
J Cyst Fibros; 2012 Jul; 11(4):332-6. PubMed ID: 22300503
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
38. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.
Roussey M; Le Bihannic A; Scotet V; Audrezet MP; Blayau M; Dagorne M; David V; Deneuville E; Giniès JL; Laurans M; Moisan-Petit V; Rault G; Vigneron P; Férec C
J Inherit Metab Dis; 2007 Aug; 30(4):613. PubMed ID: 17632692
[TBL] [Abstract][Full Text] [Related]
39. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
40. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis.
Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C
Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]